|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 8 April 2008
doi: 10.1242/jcs.021675
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |


1 Program in Genomics, Division of Genetics, Children's Hospital Boston, Boston, MA 02115, USA
2 Department of Genetics, Yale University School of Medicine, New Haven, CT 06510, USA
3 Howard Hughes Medical Institute, Children's Hospital Boston, Boston, MA 02115, USA
Author for correspondence (e-mail: kunkel{at}enders.tch.harvard.edu)
Accepted 1 February 2008
Although the contribution of bone marrow-derived cells to regenerating skeletal muscle has been repeatedly documented, there remains considerable debate as to whether this incorporation is exclusively a result of inflammatory cell fusion to regenerating myofibers or whether certain populations of bone marrow-derived cells have the capacity to differentiate into muscle. The present study uses a dual-marker approach in which GFP+ cells were intravenously transplanted into lethally irradiated β-galactosidase+ recipients to allow for simple determination of donor and host contribution to the muscle. FACS analysis of cardiotoxin-damaged muscle revealed that CD45+ bone-marrow side-population (SP) cells, a group enriched in hematopoietic stem cells, can give rise to CD45–/Sca-1+/desmin+ cells capable of myogenic differentiation. Moreover, after immunohistochemical examination of the muscles of both SP- and whole bone marrow-transplanted animals, we noted the presence of myofibers composed only of bone marrow-derived cells. Our findings suggest that a subpopulation of bone marrow SP cells contains precursor cells whose progeny have the potential to differentiate towards a muscle lineage and are capable of de novo myogenesis following transplantation and initiation of muscle repair via chemical damage.
Key words: Skeletal Muscle, Bone Marrow, Side Population, Progenitor